-
公开(公告)号:US20190000858A1
公开(公告)日:2019-01-03
申请号:US15746043
申请日:2016-07-22
IPC分类号: A61K31/5377 , C07D277/46 , C07D417/12 , C07D295/155 , C07D295/192 , C07D277/82 , A61K31/427 , A61K31/454 , A61K31/402 , A61K31/426 , A61P35/00 , A61K45/06
摘要: The present invention includes novel compounds and methods for preventing or treating diseases associated with N-linked glycosylation in a subject in need thereof. The methods comprise administering to the subject an effective amount of at least one compound of the invention.
-
公开(公告)号:US10125127B2
公开(公告)日:2018-11-13
申请号:US14648413
申请日:2013-11-27
发明人: Aloke K. Dutta
IPC分类号: C07D277/82 , C07D417/12 , C07D417/14 , A61K31/496 , A61K31/428 , A61K31/517
摘要: A compound having formula I is useful for treating a neurodegenerative disease: R1 is an C1-12 organyl group; is a C1-12 heterocyclic ring system containing 5 to 12 ring atoms and up to three heteroatoms individually selected from the group consisting of N, O, S, and Se; R2 are C1-12 organyl groups; R7, R8 are each independently, hydrogen (H), hydroxyl, oxo (i.e., carbonyl), C1-8 alkyl, C1-8 alkoxyl, C2-8 alkenyl, C2-10 alkynyl, C5-7 cycloalkyl, C5-7 cycloalkenyl, halo, C1-4 aldehyde, or —NR4q where R4 is H, C1-8 alkyl, C2-8 alkenyl, C4-8 cycloalkyl, C4-8 cycloalkenyl, or C6-10 aryl; o is 0, 1, 2, 3, or 4; A is a C6-12 aryl group, C5-12 heteroaryl group, or an optionally substituted 3-hydroxypyridin-4(1H)-one; p is an integer from 1 to 6; and Zm is absent or a divalent linking moiety; and m is an integer representing the number of time Z is repeated.
-
公开(公告)号:US20180319743A1
公开(公告)日:2018-11-08
申请号:US16033169
申请日:2018-07-11
申请人: Roche Palo Alto LLC
发明人: Robert Greenhouse , Ralph New Harris, III , Saul Jaime-Figueroa , James M. Kress , David Bruce Repke , Russell Stephen Stabler
IPC分类号: C07C317/32 , C07D233/58 , C07D277/82 , C07D239/42 , C07D239/14 , C07D235/06 , C07D233/90 , C07D233/88 , C07D233/84 , C07D233/64 , C07D233/54 , C07D233/48 , C07D233/34 , C07D233/20 , C07D231/18 , C07D209/30 , C07D207/36 , C07D207/34 , C07D207/325 , C07D207/16 , C07C317/44 , C07D233/44
CPC分类号: C07C317/32 , C07C317/44 , C07C2602/08 , C07C2602/10 , C07D207/16 , C07D207/325 , C07D207/34 , C07D207/36 , C07D209/30 , C07D231/18 , C07D233/20 , C07D233/34 , C07D233/44 , C07D233/48 , C07D233/54 , C07D233/58 , C07D233/64 , C07D233/84 , C07D233/88 , C07D233/90 , C07D235/06 , C07D239/14 , C07D239/42 , C07D277/82
摘要: The applicaton discloses pharmaceutical compounds of formula I useful for treating CNS diseases wherein m, s, R1R5, R6 and R7 are as defined herein.
-
公开(公告)号:US10072135B2
公开(公告)日:2018-09-11
申请号:US15109385
申请日:2014-12-19
IPC分类号: C07D277/82 , C08K5/47 , C09J11/06 , C09J181/02 , G01N21/25 , G01N33/44 , C09B29/033 , C08K5/00 , G01N21/17
CPC分类号: C08K5/47 , C07D277/82 , C08K5/0041 , C09B29/0088 , C09B29/0813 , C09B29/0823 , C09B69/106 , C09J11/06 , C09J181/02 , G01N21/25 , G01N33/442 , G01N2021/1748 , G01N2021/1761 , C08L81/02
摘要: A curable composition having a polythiol; at least one unsaturated compound comprising two or more carbon-carbon double bonds, carbon-carbon triple bonds, or a combination thereof; and a dye compound represented by formula: A crosslinked composition prepared from the curable composition, a method for indicating curing in a curable composition, and a method of stabilizing a curable composition comprising a polythiol and at least one unsaturated compound comprising two or more carbon-carbon double bonds, carbon-carbon triple bonds, or a combination thereof are also disclosed.
-
公开(公告)号:US20180230106A1
公开(公告)日:2018-08-16
申请号:US15751555
申请日:2016-08-11
IPC分类号: C07D233/88 , C07D277/50 , C07D235/30 , C07D277/82 , G01N33/542 , A61K41/00 , G01N33/58 , A61K47/54
CPC分类号: C07D233/88 , A61K41/0042 , A61K47/545 , C07D235/30 , C07D277/50 , C07D277/82 , G01N33/542 , G01N33/582
摘要: Triazabutadiene molecules for use in applications. e.g., those involving fluorogenic molecules, e.g., triazabutadiene molecules configured to generate a fluorescent compound when combined with a second molecule, e.g., upon reaction with a tyrosine molecule or other appropriate molecule; and protected triazabutadiene molecules that are stable in acidic conditions and are adapted to release an active (e.g., acid-labile} triazabutadiene molecule upon appropriate conditions, and methods for producing and using said protected or releasable triazabutadiene molecules (and products of cleavage).
-
公开(公告)号:US20180099921A1
公开(公告)日:2018-04-12
申请号:US15560646
申请日:2016-03-30
申请人: ZEON CORPORATION
发明人: Kei SAKAMOTO , Kumi OKUYAMA , Kanako SANUKI
IPC分类号: C07C67/58 , C07C67/14 , C07C69/75 , C07D277/82
摘要: Disclosed is a mixture containing compound (I) and polymerizable compound (II) wherein compound (I) accounts for 50 mol % or more of the entire mixture and 1,4-cyclohexanedicarboxylic acid accounts for less than 5 mol % of the entire mixture; a method of producing the mixture which includes reacting in a water-immiscible organic solvent 1,4-cyclohexanedicarboxylic acid dichloride with compound (IV) in the presence of a base, and washing the obtained reaction solution with a weakly acidic buffer solution; etc. The disclosure provides mixtures useful for low-cost production of polymerizable compounds which have low melting points suitable for practical use, show superior solubility to general-purpose solvents, can be produced at low costs, and allow for provision of optical films capable of uniform polarized light conversion over a wide wavelength range, and methods of producing the mixtures. where A represents hydrogen, methyl group or chlorine, and n represents an integer of 1 to 20.
-
公开(公告)号:US20180078530A1
公开(公告)日:2018-03-22
申请号:US15787049
申请日:2017-10-18
申请人: Kowa Co., Ltd.
IPC分类号: A61K31/423 , C07D277/82 , C07D231/56 , C07D263/58
CPC分类号: A61K31/423 , C07D231/56 , C07D263/58 , C07D277/82
摘要: An FGF21 production promoting agent containing, as an active ingredient, a compound represented by the following formula (1): wherein each of R1 and R2, which may be identical to or different from each other, represents, for example, a hydrogen atom; each of R3a, R3b, R4a, and R4b, which may be identical to or different from one another, represents, for example, a hydrogen atom or a halogen atom, or R3a and R3b or R4a and R4b may bond together to form an alkylenedioxy group; X represents an oxygen atom, a sulfur atom, or N—R5 (R5 represents, for example, a hydrogen atom or a C1-4 alkyl group); Y represents, for example, an oxygen atom, an S(O)l group (l is a number of from 0 to 2), or a carbonyl group; Z represents CH or N; n is a number of from 1 to 6; and m is a number from 2 to 6, a salt of the compound, or a solvate of the compound or the salt.
-
公开(公告)号:US20180037744A1
公开(公告)日:2018-02-08
申请号:US15537516
申请日:2015-11-27
申请人: Merck Patent GmbH
发明人: LOUISE DIANE FARRAND , Jonathan Henry WILSON , Mark JAMES , Christopher LUTZ , Nathan SMITH , Mark John GOULDING
IPC分类号: C09B69/10 , G02F1/167 , C07D285/08 , C07D277/82 , C08F293/00 , C07D265/34
CPC分类号: C09B69/106 , C07D265/34 , C07D277/82 , C07D285/08 , C08F220/14 , C08F293/00 , C09B62/008 , C09B69/101 , C09B69/109 , G02F1/167 , G02F2001/1678 , G02F2202/022
摘要: This invention relates to polymer particles preferably with surface functionality for charge retention, a process for their preparation, the use of these particles for the preparation of an electrophoretic device, electrophoretic displays comprising such particle, and new polymerisable dyes.
-
公开(公告)号:US20180022716A1
公开(公告)日:2018-01-25
申请号:US15547949
申请日:2016-02-16
申请人: DIC Corporation
IPC分类号: C07D277/82 , C07D417/12 , C07D409/14 , C07C243/22 , C07D405/12 , C07D277/84 , C07D417/14 , C07D263/58 , C07D513/04 , C07D401/12 , C07D303/27 , C07D241/42 , C07C323/52 , C07D317/46 , C07D333/58 , C07D209/56 , C07D495/04 , C07D403/12 , C07D413/14 , C08F22/10 , C09K19/34 , C09K19/32 , C07C243/20
CPC分类号: C07D277/82 , C07C243/20 , C07C243/22 , C07C251/86 , C07C251/88 , C07C323/52 , C07C2602/42 , C07C2603/18 , C07C2603/24 , C07C2603/34 , C07D209/56 , C07D241/42 , C07D263/58 , C07D277/84 , C07D303/27 , C07D317/46 , C07D333/58 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/14 , C07D413/14 , C07D417/12 , C07D417/14 , C07D495/04 , C07D513/04 , C08F2/48 , C08F2/50 , C08F20/26 , C08F22/10 , C08F220/26 , C08F222/1006 , C09K19/2014 , C09K19/3068 , C09K19/32 , C09K19/322 , C09K19/3491 , C09K19/3497 , C09K2019/0448 , C09K2019/2078 , C09K2019/328
摘要: The present invention provides a polymerizable compound having high storage stability without causing crystal precipitation when added to a polymerizable composition. The present invention also provides a polymerizable composition containing the compound. When the filmy polymer produced through polymerization of the polymerizable composition is irradiated with UV light, it hardly discolors or peels from substrate. Further, the present invention provides a polymer produced through polymerization of the polymerizable composition and an optically anisotropic body using the polymer.
-
50.
公开(公告)号:US20180000772A1
公开(公告)日:2018-01-04
申请号:US15545975
申请日:2016-01-27
申请人: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY , THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
发明人: David J. Augeri , Anthony F. Bencivenga , Adam Blanden , Darren R. Carpizo , John A. Gilleran , Spencer David Kimball , Stewart N. Loh , Xin Yu
IPC分类号: A61K31/315 , C07D413/12 , C07D403/12 , C07D401/12 , C07D277/82 , A61K31/4439 , A61K31/4436 , C07D417/12 , A61K31/443
摘要: The invention provides complexes of Zn2+ of formulae (la) and (IIa) that are useful for treating cancer, as well as compositions and kits comprising such complexes.
-
-
-
-
-
-
-
-
-